
Low Dose Naltrexone (LDN) is a customized, compounded medication used off-label to support immune modulation and manage chronic pain or inflammatory conditions. By using a fraction of the standard dose, LDN aims to boost the body’s endorphin production, offering a unique approach to wellness for those with autoimmune or chronic sensitivities.
Low Dose Naltrexone (LDN) capsules are a compounded pharmaceutical prepared by a licensed pharmacist to meet specific dosage requirements not available in commercially manufactured forms. While Naltrexone is FDA-approved at higher doses (typically 50mg to 100mg) for treating alcohol and opioid dependence, LDN utilizes significantly smaller amounts—usually ranging from 0.5mg to 4.5mg.
The mechanism of LDN is believed to involve a brief, temporary blockade of opioid receptors. This "rebound effect" signals the body to increase the production of endogenous opioids (endorphins) and upregulate opioid receptors. Additionally, LDN is studied for its ability to reduce glial cell activation in the central nervous system, which may help decrease neuroinflammation. Because of these unique properties, practitioners often prescribe LDN as a complementary therapy for conditions such as fibromyalgia, Crohn’s disease, multiple sclerosis, and various autoimmune disorders. Because it is compounded, capsules can be formulated without common fillers like lactose or gluten to accommodate patients with specific allergies.